Jiuqiang Bio: In the first half of 2021, the company achieved a year-on-year increase of 215.81% in sales revenue of traditional biochemical, hemagglutination reagents and immunohistochemical antibodies

Post date April 13, 2022 — 17:31 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Risen Oriental: The devaluation of the renminbi has a positive effect on the company's export business and will have a certain positive impact on performance_Oriental Fortune Net

May 20, 2022 — 18:00

Risen Oriental: The company has a stable customer base in the United States_ Oriental Fortune Net

May 20, 2022 — 18:00

Intelligent automatic control: the company's products can be applied to the wind and solar power industry, which has a positive effect on the company's performance

May 20, 2022 — 17:59

Kangtai Medical: The company's decline in sales of blood oxygen products in 2021 is mainly affected by changes in demand and the high base of the previous year

May 20, 2022 — 17:56

Oxycon (002913): Announcement on the progress of Oxycon Technology Co., Ltd. on the use of some idle self-owned funds for cash management- CFi.CN Zhongcai Network

May 20, 2022 — 17:56

Huichuangda: In 2021, the company will strengthen the research and development of automated production lines, further improve the degree of automation of production lines, enhance production efficiency, and realize automated production of various processes

May 20, 2022 — 17:55

Runyang Technology: The company's research and development projects are mainly the research and development of high-strength IXPE foam materials, the research and development of thermally conductive and insulating polyethylene foam materials, and the research and development of radiation cross-linked polybutylene succinate foam materials, etc.

May 20, 2022 — 17:55

The secretary of the board of CTI Testing replied: The company hopes to make a modest contribution to the fight against the epidemic – yqqlm

May 20, 2022 — 17:55

[Opportunity Discovery] 11 major transportation project packages in the "14th Five-Year Plan" announced to pay attention to the relevant industry chain_ Oriental Fortune Net

May 20, 2022 — 17:54

Home » News » Jiuqiang Bio: In the first half of 2021, the company achieved a year-on-year increase of 215.81% in sales revenue of traditional biochemical, hemagglutination reagents and immunohistochemical antibodies